StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

XBiotech's price to sales ratio was 465.7× on Jan 31, 2024, against 16.1× a year earlier. Over the last 4 years it ranged from 9.7× to 465.7×, with a median of 17.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024465.7×+59.9
2023Dec 29, 2023405.8×+392.8
2022Dec 30, 202213.0×−4.6
2021Dec 31, 202117.7×+5.8
2020Dec 31, 202011.8×–

More XBiotech figures

See a number that looks wrong?